Type 1 diabetes and immune-based therapies

Despite major advances in understanding the immunopathology of type 1 diabetes, the promise of successful immune-based therapies has so far been unfulfilled. This two-paper Series from The Lancet Diabetes & Endocrinology covers the current challenges faced in the development of immune-based thera...